UNSPSC 51434000: Antihypertensive pyrrolidines

Antihypertensive drugs made from tetrahydropyrroles.

UNSPSC 51434000 Antihypertensive pyrrolidines is a Class code covering pharmaceutical products used in emergency medical response and state health benefit programs. State and local governments procure antihypertensive medications—particularly labetalol and diltiazem formulations—for emergency medical services, health department inventories, and pharmacy benefit programs serving state employees and Medicaid beneficiaries. Issuing bodies include municipal fire and rescue departments, state health and human services commissions, and state-administered cooperative purchasing alliances that aggregate demand across multiple jurisdictions. Recent activity shows a mix of direct procurement by individual cities and statewide solicitations through multistate cooperative purchasing vehicles that standardize pricing and supply chains across participating states and localities.

Geographic spread centers on Texas, Florida, and Minnesota, with broader multistate reach through cooperative purchasing programs. The City of Tampa's Hillsborough County Fire Rescue issued an IFB (Solicitation 26P00188, due April 8, 2026) for Advanced Life Support Medications including 370 units of labetalol HCI 100mg vials and 1,020 units of diltiazem 25mg vials, with an estimated contract value of $40,000 and a Small Local Business Enterprise (SLBE) 5 percent bid discount available. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted an RFP (S1070000015802, due March 26, 2026) to establish contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with products required in market by May 15, 2026 and contract effectiveness July 1, 2026. The Texas Health and Human Services Commission issued an RFI (HHS0017013, posted March 27, 2026) to gather vendor capabilities for direct-to-manufacturer prescription fulfillment programs serving state pharmacy benefits, signaling future formal procurement development in that market.